SCHEMBL21742487

SCHEMBL21742487

COCc1ccc(C(=O)NCCN)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK2 Q9NRA0 1/20 0.59
CYP1A2 P05177 1/20 0.58
TSHR P16473 1/20 0.58
NFKB1 P19838 1/20 0.58
MAOB P27338 1/20 0.58
KMT2A Q03164 3/20 0.57
MEN1 O00255 1/20 0.57
BLM P54132 1/20 0.57
PMP22 Q01453 1/20 0.57
ALDH1A1 P00352 2/20 0.56
BRD4 O60885 1/20 0.49
TERT O14746 2/20 0.49
HPGD P15428 1/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
LOXL2 Q9Y4K0 1/20 0.46
ESRRB O95718 1/20 0.46
ESRRG P62508 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21742543 0.89 ALDH1A1 (0.59) SPHK2CYP1A2TSHRNFKB1MAOB
SCHEMBL19634295 0.85 SPHK2 (0.58) SPHK2CYP1A2KMT2AALDH1A1BRD4
SCHEMBL3861146 0.82 MAOB (0.81) SPHK2CYP1A2TSHRNFKB1MAOB
SCHEMBL12141627 0.81 TSHR (0.64) SPHK2CYP1A2TSHRNFKB1MAOB
SCHEMBL16213815 0.81 L3MBTL1 (0.63) KMT2AMEN1ALDH1A1HPGDNPC1
SCHEMBL23254636 0.81 CYP1A2 (0.68) SPHK2CYP1A2TSHRNFKB1MAOB
SCHEMBL28975147 0.80 SPHK2 (0.55) SPHK2CYP1A2TSHRNFKB1MAOB
SCHEMBL7207554 0.80 NPC1 (0.73) CYP1A2TSHRNFKB1MAOBKMT2A
SCHEMBL28830270 0.79 CYP1A2 (0.70) SPHK2CYP1A2TSHRNFKB1MAOB
Hydrochloric Acid SCHEMBL9584772 0.79 NPC1 (0.71) CYP1A2TSHRNFKB1MAOBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210169911-A1 PURINE AND PYRIMIDINE NUCLEOTIDES AS ECTO-5'-NUCLEOTIDASE INHIBITORS THE UNITED STATES OF AMERICA,AS REPRESENTED BY THE SECRETARY,DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2021-06-10 US disclosed
WO-2020037275-A1 PURINE AND PYRIMIDINE NUCLEOTIDES AS ECTO-5'-NUCLEOTIDASE INHIBITORS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2020-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210169911-A1 PURINE AND PYRIMIDINE NUCLEOTIDES AS ECTO-5'-NUCLEOTIDASE INHIBITORS NUDT1, NTPCR, NT5C2 SPHK2 1499/4885CYP1A2 3563/4885TSHR 2850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.